|
1
Diffuse Hormonal Systems
|
Hans Clevers and Talya L. Dayton |
|
2
Carcinoid Tumors
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Marybeth S. Hughes, M.D., F.A.C.S., Eric Feliberti, MD, FACS, Roger R Perry, M.D., FACS, Carolina Casellini, M.D., Mark Sinesi, MD, PhD, Harlan Vingan MD and Lester Johnson, MD |
|
3
Multiple Endocrine Neoplasia Type 1
|
Carolina R.C. Pieterman, MD, PhD, Rachel S. van Leeuwaarde, MD, PhD, Medard S. M. van den Broek, MD, PhD, Bernadette P. M. van Nesselrooij, MD and Gerlof D. Valk, MD, PhD |
|
4
Multiple Endocrine Neoplasia Type 2
|
Mark J.T. van Treijen, MD, Lisa H. de Vries, MD, Doenja Hertog, MD, Annemarie A. Verrijn Stuart, MD, PhD, Bernadette P. M. van Nesselrooij, MD and Gerlof D. Valk, MD, PhD |
|
5
Multiple Endocrine Neoplasia Type 4
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
6
Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): New Developments
|
Laura Mariën, Msc, Odeta Islam, MD, Laura Van Mileghem, MD, Willem Lybaert, MD, Marc Peeters, MD, PhD and Timon Vandamme, MD, PhD |
|
7
Gastrinoma
|
Robert T. Jensen, MD |
|
8
Insulinoma
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
9
Vasoactive Intestinal Peptide-Secreting Tumor (VIPoma)
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
10
Glucagon & Glucagonoma Syndrome
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
11
Somatostatinoma
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
12
CCKoma
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
13
Ghrelinoma
|
Wouter T. Zandee, MD, PhD, Johannes Hofland, MD, PhD, Aart J. van de Lely, MD, PhD and Wouter W. de Herder, MD, PhD |
|
14
Paraneoplastic Syndromes Related to Neuroendocrine Tumors
|
Marina Tsoli, MD, PhD, Georgios K. Dimitriadis, Ioannis I. Androulakis, Gregory Kaltsas, MD, PHD, FRCP and Ashley Grossman, BA, BSc, MD, FRCP, FMedSci |
